Christopher Liu
Stock Analyst at Leerink Partners
(3.12)
# 498
Out of 5,218 analysts
5
Total ratings
100.00%
Success rate
40.47%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Relay Therapeutics | Maintains: Outperform | 19 18 | 4.68 | 284.62% | 1 | Dec 4, 2024 | |
IDEAYA Biosciences | Downgrades: Market Perform | 41 27 | 25.19 | 7.19% | 2 | Nov 5, 2024 | |
Nuvalent | Initiates Coverage On: Market Perform | 42 | 86.68 | -51.55% | 1 | Aug 8, 2023 | |
Exelixis | Initiates Coverage On: Market Perform | 18 | 35.01 | -48.59% | 1 | Aug 8, 2023 |